Neuropyschological and behavioral outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders [0.03%]
胎儿酒精谱系障碍儿童磁共振影像的神经心理学和行为结果研究
Susan J Astley,Heather Carmichael Olson,Kimberly Kerns et al.
Susan J Astley et al.
Background: Clinical and research advancements in the field of fetal alcohol spectrum disorders (FASD) require accurate and valid identification of FASD clinical subgroups. ...
Controlled Clinical Trial
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique. 2009 Winter;16(1):e178-201. DOI: 2009
A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities [0.03%]
加拿大药学与治疗委员会的范围和职责调查报告
Nicole Mittmann,Sandra Knowles
Nicole Mittmann
Background: Pharmacy and Therapeutics (P&T) committees have traditionally evaluated and developed policies for the clinical use of medications and for ensuring safe and effective drug use and administration. ...
The ten commandments of giving medications to children: the questions you should get answers to by your physician or pharmacist before giving any medication to your child [0.03%]
给儿童用药的十大原则：在给孩子服用任何药物之前，你应该向医生或药剂师询问的问题
Gideon Koren
Gideon Koren
Medications may be important to improve or maintain your child's health. However, quite often errors are made while giving medications to babies and children. Here are questions parents should ask to avoid such errors. It is important for p...
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin [0.03%]
中度肝功能不全对西他列汀药动学的影响
Elizabeth M Migoya,Catherine H Stevens,Arthur J Bergman et al.
Elizabeth M Migoya et al.
Background: Sitagliptin is a highly selective dipeptidyl peptidase-4 inhibitor for the treatment of patients with type 2 diabetes. Sitagliptin is primarily excreted by renal elimination as unchanged drug, with only a smal...
CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip [0.03%]
加沙地带健康志愿者和血液系统恶性肿瘤儿童中CYP2C19基因型的研究
Abu-Eid I Sameer,Gharbieh M Amany,Abed A Abdela et al.
Abu-Eid I Sameer et al.
Background: Cytochrome P450 2C19 (CYP2C19) participates in the metabolism of many clinically important drugs and xenobiotic compounds. Genetic polymorphisms of the CYP2C19 gene are described to have possible effect on dru...
Vida Stankus,Brenda Hemmelgarn,Norm R C Campbell et al.
Vida Stankus et al.
Objective: To quantify the cost-savings that could be realized by switching patients from two separate agents, ACE inhibitor/ARB and thiazide diuretic, to a fixed dose combination product. ...
Longitudinal Outcomes of GastroIntestinal symptoms in Canada (LOGIC): key factors for an effective patient retention in observational studies [0.03%]
加拿大胃肠症状纵向研究（逻辑研究）：观察性研究中有效保留患者的要素
R Balshaw,S Khorasheh,M Barbeau et al.
R Balshaw et al.
Background: Longitudinal Outcomes of GastroIntestinal symptoms in Canada (LOGIC) is an ongoing study on irritable bowel syndrome (IBS) treatment patterns and health outcomes in routine Canadian clinical practice. Advancem...
Child guardianship in a Canadian home visitation program for women who use substances in the perinatal period [0.03%]
加拿大孕期妇女用药的家庭访问项目中的儿童监护权问题
Rosanne M T Mills,Jodi E Siever,Matt Hicks et al.
Rosanne M T Mills et al.
Background: Retaining guardianship of one's infant is often a priority for pregnant women who use substances, and may be beneficial to infants when they are safe in their mothers' care. Previous studies from the United St...
Strategic opportunities for effective optimal prescribing and medication management [0.03%]
有效且最优的处方和药物管理的战略机遇
Ingrid S Sketris,Ethel M Langille Ingram,Heather L Lummis
Ingrid S Sketris
Background: Canadians receive over 422 million prescriptions and spend over $26 billion annually on drugs. Yet, we do not systematically capture information on whether the right drugs reach the right people with the inten...
Brenda Stade,Alaa Ali,Dainel Bennett et al.
Brenda Stade et al.
Background: In Canada the incidence of Fetal Alcohol Spectrum Disorder (FASD) is estimated to be 1 in 100 live births. FASD is the leading cause of developmental and cognitive disabilities in Canada. Only one study has ex...